Kimberly G. Brodovicz
Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Medication Adherence and Compliance, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Hepatitis B Vaccination and the Risk of Multiple Sclerosis(2001)432 cited
- → Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review(2017)244 cited
- → Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active Antiretroviral Therapy(2003)220 cited
- → Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care(2019)216 cited
- → Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients(2012)115 cited
- → Risk of acute renal failure in patients with Type 2 diabetes mellitus(2011)110 cited
- → Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes(2014)85 cited
- → Claims‐based studies of oral glucose‐lowering medications can achieve balance in critical clinical variables only observed in electronic health records(2017)79 cited
- → Disease burden of urinary tract infections among type 2 diabetes mellitus patients in the U.S.(2014)78 cited
- → Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure(2020)69 cited